Investigating the role of exosomes and the cell fate regulator, ASCL1 in driving, and maintaining lethal Neuroendocrine transdifferentiation of prostate cancer

Project Details

StatusFinished
Effective start/end date1/04/21 → 31/05/24

Funding

  • Melville Trust for Care and Cure of Cancer: £85,215.99